| Quarterly Financials | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 97 | 102 | 77 | 80 | 89 | 73 | 57 | 49 | 59 | 67 |
| Expenses | 90 | 91 | 68 | 71 | 80 | 63 | 62 | 52 | 60 | 73 |
| EBITDA | 7 | 12 | 8 | 9 | 9 | 10 | -5 | -3 | -1 | -6 |
| Operating Profit % | 7 % | 11 % | 11 % | 11 % | 10 % | 14 % | -8 % | -6 % | -3 % | -8 % |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 |
| Interest | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 3 |
| Profit Before Tax | 0 | 4 | 1 | 1 | 1 | 2 | -13 | -13 | -10 | -13 |
| Tax | -1 | 0 | -2 | -2 | 0 | 2 | 1 | -5 | 0 | 0 |
| Net Profit | 1 | 4 | 3 | 3 | 1 | 0 | -14 | -7 | -10 | -13 |
| EPS in ₹ | 0.31 | 2.23 | 1.70 | 1.70 | 0.81 | 0.04 | -8.72 | -4.64 | -6.21 | -8.48 |
Mangalam Drugs & Organics
Mangalam Drugs & Organics
29.41
-1.10
(-3.61%)
Market Cap
46.55 Cr
PE Ratio
-1.09
Volume
31,637.00
Day High - Low
30.99 - 29.32
52W High-Low
95.00 - 22.80
Key Fundamentals
Market Cap
46.55 Cr
EPS
-28.05
PE Ratio
-1.09
PB Ratio
0.50
Book Value
60.64
EBITDA
-14.91
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
4.51
Debt to Equity
0.73
Actual
Company News
View All News
Mangalam Drugs & Organics has initiated a postal ballot to re-appoint Shri Praveen Saxena as Independent Director for a second five-year term from March 21, 2026 to March 20, 2031.
Mangalam Drugs & Organics reported a standalone net loss of Rs. 4,381.42 lakhs for FY26, reversing a net profit of Rs. 692.43 lakhs in FY25, as revenue fell sharply to Rs. 23,213.27 lakhs.
Mangalam Drugs Board Meet Set for May 14, 2026
May 06, 2026
May 06, 2026Mangalam Drugs & Organics schedules board meeting on May 14, 2026 to consider audited financial results for Q4 and full year ended March 31, 2026.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,844.60 | #1 4,42,581.33 | 41.43 | #1 54,729.00 | 9.71 | #1 10,980 | 16.07 | 54.75 | |
6,887.00 | 1,82,828.21 | 73.47 | 9,712.00 | 18.67 | 2,191 | -1.02 | 66.48 | |
4,486.20 | 1,51,833.39 | 66.60 | 11,539.40 | 6.99 | 1,911 | 26.24 | 61.90 | |
1,399.20 | 1,13,024.67 | 29.32 | 27,711.70 | -2.46 | 3,783 | -55.32 | 61.92 | |
1,307.20 | 1,09,104.54 | 26.47 | 33,593.30 | -0.44 | 3,998 | -86.05 | 52.61 | |
1,038.95 | 1,04,542.68 | 20.35 | 26,719.70 | 13.65 | 5,242 | 7.82 | 69.40 | |
2,281.80 | 1,04,288.12 | #1 19.51 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 47.33 | |
2,479.40 | 1,02,350.89 | 53.58 | 14,277.60 | 12.03 | 1,750 | 31.75 | 62.34 | |
1,463.50 | 85,000.32 | 25.77 | 32,345.60 | 9.43 | 3,484 | 1.99 | 52.91 | |
1,343.50 | 72,529.73 | 81.91 | 6,812.90 | #1 21.03 | 884 | 21.18 | 77.10 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
-27.16 %
Net Income Growth
-829.25 %
Cash Flow Change
989.26 %
ROE
-167.51 %
ROCE
571.43 %
EBITDA Margin (Avg.)
-156.14 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2024 | 2025 | 2026 |
| Total Assets | 334 | 366 | 315 |
| Fixed Assets | 148 | 163 | 159 |
| Current Assets | 176 | 199 | 156 |
| Capital Work in Progress | 8 | 3 | 0 |
| Investments | 0 | 0 | 103 |
| Other Assets | 178 | 201 | 0 |
| Total Equity & Liabilities | 334 | 366 | 315 |
| Current Liabilities | 164 | 192 | 197 |
| Non Current Liabilities | 34 | 26 | 15 |
| Total Equity | 136 | 149 | 103 |
| Reserve & Surplus | 120 | 133 | 87 |
| Share Capital | 16 | 16 | 16 |
Cash Flow
| Cash Flow | 2024 | 2025 |
| Net Cash Flow | -3 | 1 |
| Investing Activities | -12 | -20 |
| Operating Activities | 4 | 43 |
| Financing Activities | 5 | -22 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 50.53 % | 50.53 % | 50.53 % | 50.53 % | 50.53 % | 50.42 % | 50.42 % | 50.32 % | 50.32 % | 50.32 % | 50.32 % | 50.32 % | 50.32 % | 50.32 % | 50.30 % | 50.30 % | 50.30 % | 50.30 % | 50.30 % | 35.64 % | 35.65 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.10 % | 0.26 % | 0.21 % | 0.11 % | 0.11 % | 0.47 % | 0.53 % | 0.11 % | 0.13 % | 0.32 % |
| DIIs | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 44.27 % | 42.68 % | 44.53 % | 44.39 % | 43.85 % | 44.18 % | 44.12 % | 44.27 % | 44.22 % | 44.64 % | 44.54 % | 44.43 % | 44.22 % | 44.70 % | 44.91 % | 44.78 % | 44.55 % | 44.53 % | 45.00 % | 57.52 % | 60.14 % |
| Others | 5.19 % | 6.78 % | 4.93 % | 5.07 % | 5.61 % | 5.40 % | 5.46 % | 5.41 % | 5.46 % | 5.05 % | 5.14 % | 5.15 % | 5.20 % | 4.77 % | 4.67 % | 4.80 % | 4.68 % | 4.63 % | 4.59 % | 6.70 % | 3.89 % |
| No of Share Holders | 0 | 20,520 | 21,827 | 21,071 | 20,668 | 20,084 | 18,988 | 18,483 | 17,943 | 17,890 | 17,978 | 18,610 | 19,173 | 19,312 | 19,508 | 19,679 | 19,697 | 19,728 | 19,881 | 21,227 | 25,140 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 26 Sept 2024 |  Annual General Meeting | NA | 26 Sept 2024 | 130.33 | 124.37 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 110.36 | 105.03 |
| 13 Feb 2025 | Quarterly Result Announcement | NA | 13 Feb 2025 | 109.00 | 110.75 |
| 17 May 2025 | Quarterly Result Announcement | NA | 17 May 2025 | 78.66 | 82.30 |
| 07 Aug 2025 | Quarterly Result Announcement | NA | 07 Aug 2025 | 87.56 | 84.03 |
| 12 Aug 2025 |  Extraordinary General Meeting | NA | 12 Aug 2025 | 85.56 | 77.13 |
| 29 Sept 2025 | Annual General Meeting | NA | 29 Sept 2025 | 78.43 | 72.22 |
| 20 Nov 2025 | Quarterly Result Announcement | NA | 20 Nov 2025 | 66.04 | 54.61 |
| 15 Jan 2026 | Quarterly Result Announcement | NA | 15 Jan 2026 | 33.42 | 44.77 |
| 14 May 2026 | Quarterly Result Announcement | NA | 14 May 2026 | 30.05 | 30.50 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication3 days ago
3 days agoDispatch Of Postal Ballot Notice Dated 18.05.2026 By Way Of Remote E- Voting For Taking Shareholders Approval For Reappointment Of Shri Praveen Saxena (Independent Director DIN: 03199264) For Second Term Of 5 Consecutive Years4 days ago
4 days agoDefaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure6 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication7 days ago
7 days agoApproval Of Audited Financial Results For The Quarter Ended 31St March 20268 days ago
8 days agoBoard Meeting Outcome for Outcome Of Board Meeting Held On 14Th May 2026 For Declaration Of Audited Financial Results(Standalone & Consolidated) Of The Company For The Quarter And Year Ended 31St March 20268 days ago
8 days agoBoard Meeting Intimation for Intimation Of Board Meeting To Be Held On 14Th May 2026 Inter-Alia To Approve Audited Financial Results(Standalone & Consolidated) Of The Company For The Period Ended 31St March 2026May 06, 2026
May 06, 2026Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Apr 29, 2026
Apr 29, 2026Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Apr 29, 2026
Apr 29, 2026Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Apr 29, 2026
Apr 29, 2026Announcement under Regulation 30 (LODR)-Change in ManagementApr 17, 2026
Apr 17, 2026Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerApr 17, 2026
Apr 17, 2026Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent DisclosureApr 16, 2026
Apr 16, 2026Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Apr 10, 2026
Apr 10, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 06, 2026
Apr 06, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMar 26, 2026
Mar 26, 2026Board Meeting Outcome for Outcome Of Board Meeting For Resignation Tendered By CS Anuradha Pandey Accepted By The Board Approval For The Appointment Of New Company Secretary Nominated By NRC Ms. Shweta Patel.Mar 26, 2026
Mar 26, 2026Board Meeting Intimation for Board Meeting Intimation To Be Held On 26Th March 2026Mar 24, 2026
Mar 24, 2026Closure of Trading WindowMar 24, 2026
Mar 24, 2026Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent DisclosureMar 18, 2026
Mar 18, 2026Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Mar 18, 2026
Mar 18, 2026Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Mar 18, 2026
Mar 18, 2026Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent DisclosureMar 17, 2026
Mar 17, 2026Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent DisclosureMar 17, 2026
Mar 17, 2026Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent DisclosureMar 17, 2026
Mar 17, 2026Announcement under Regulation 30 (LODR)-Change in ManagementFeb 06, 2026
Feb 06, 2026Board Meeting Outcome for Outcome Of Board Meeting Dated 6Th February 2026Feb 06, 2026
Feb 06, 2026Board Meeting Intimation for To Consider And Approve Appointment Of Chief Financial Officer Of The Company And Any Other Businesses.Feb 04, 2026
Feb 04, 2026Announcement under Regulation 30 (LODR)-Credit RatingFeb 03, 2026
Feb 03, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJan 17, 2026
Jan 17, 2026Announcement under Regulation 30 (LODR)-Resignation of DirectorJan 17, 2026
Jan 17, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 16, 2026
Jan 16, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJan 15, 2026
Jan 15, 2026Declaration Of Un-Audited Financial Results For The Quarter Ended 31St December 2025Jan 15, 2026
Jan 15, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On 15Th January 2026 Inter Alia To Approve Un-Audited Financial Results For The Quarter Ended 31St December 2025Jan 15, 2026
Jan 15, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Jan 12, 2026Board Meeting Intimation for Declaration Of Un-Audited Financial Results For The Quarter Ended 31St December 2025.Jan 07, 2026
Jan 07, 2026Revert To The Query Raised By BSE Surveillance Department Dated 5Th January 2026 Regarding Clarification In Price Movement.Jan 07, 2026
Jan 07, 2026Clarification sought from Mangalam Drugs & Organics LtdJan 05, 2026
Jan 05, 2026Closure of Trading WindowJan 01, 2026
Jan 01, 2026Explanation To The Intimation Filed On 29Th March 2025 Regarding Resignation Of Chief Financial Officer Of The Company.Dec 24, 2025
Dec 24, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderNov 25, 2025
Nov 25, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 21, 2025
Nov 21, 2025Declaration Of Un-Audited Financial Results For The Quarter Ended 30Th September 2025Nov 20, 2025
Nov 20, 2025Board Meeting Outcome for Intimation Of Outcome Of Board Meeting Held On 20Th November 2025 At 12:00 P.M. To Approve Standalone And Consolidated Un-Audited Financial Results For The Quarter Ended 30Th September 2025Nov 20, 2025
Nov 20, 2025Defaults under Para A sub-paragraph 6 of Schedule III-Initial DisclosureNov 18, 2025
Nov 18, 2025Results-Delay in Financial ResultsNov 13, 2025
Nov 13, 2025Board Meeting Intimation for Postponement Of Board Meeting To Be Held On 20Th November 2025Nov 13, 2025
Nov 13, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Nov 11, 2025
Nov 11, 2025Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 13Th November 2025 To Consider And Approve Un-Audited Financial Results(Standalone And Consolidated) For The Quarter Ended 30Th September 2025.Nov 05, 2025
Nov 05, 2025Technical Indicators
RSI(14)
Neutral 53.23
ATR(14)
Volatile 1.13
STOCH(9,6)
Neutral 57.48
STOCH RSI(14)
Neutral 46.12
MACD(12,26)
Bullish 0.11
ADX(14)
Weak Trend 15.44
UO(9)
Bearish 58.01
ROC(12)
Uptrend And Accelerating 3.56
WillR(14)
Neutral -32.34
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
